Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Change in Inventory (2021 - 2025)

HeartSciences posted quarterly Change in Inventory of $7778.0 for Q4 2025, down 21.18% year-on-year from $9868.0 in Q4 2024, and up 1123.42% on a QoQ basis from -$760.0 in Q3 2025.

HeartSciences (HSCS) has 5 years of Change in Inventory data on file, last reported at $7778.0 in Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 21.18% year-over-year to $7778.0; the trailing twelve-month figure through Jan 2026 stood at $5138.0 (up 128.34% YoY), and the FY2025 full-year result was $21088.0, up 144.7% from the prior year.
  • Change in Inventory for Q4 2025 stood at $7778.0, up from -$760.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $13860.0 in Q3 2024 and bottomed at -$41099.0 in Q2 2024.
  • The 5-year median for Change in Inventory is -$760.0 (2023), against an average of -$6131.3.
  • The widest annual swing landed in 2022, when Change in Inventory jumped 110.49%; it then sank 7372.55% in 2024.
  • A 5-year view of Change in Inventory shows it stood at -$23397.0 in 2021, then soared by 115.09% to $3530.0 in 2022, then slumped by 115.58% to -$550.0 in 2023, then soared by 1894.18% to $9868.0 in 2024, then dropped by 21.18% to $7778.0 in 2025.
  • The last three Change in Inventory figures came in at $7778.0 (Q4 2025), -$760.0 (Q3 2025), and -$1880.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 420.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 127.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 131.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 177.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.60 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -264.59 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 65.20 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 171.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -38.50 Mn
10 HeartSciences 4.56 Mn 1.16 Mn - -

Historic Data

Download Data 🔒
DateValue
Oct 31, 2025 7,778.00
Oct 31, 2025 7,778.00
Jul 31, 2025 -760.00
Jul 31, 2025 -760.00
Apr 30, 2025 -1,880.00
Apr 30, 2025 -1,880.00
Jan 31, 2025 -760.00
Jan 31, 2025 -760.00
Oct 31, 2024 9,868.00
Oct 31, 2024 9,868.00
Jul 31, 2024 13,860.00
Jul 31, 2024 13,860.00
Apr 30, 2024 -41,099.00
Apr 30, 2024 -41,099.00
Jan 31, 2024 -4,561.00
Jan 31, 2024 -4,561.00
Apr 30, 2023 -550.00
Apr 30, 2023 -550.00
Jan 31, 2023 -760.00
Jan 31, 2023 -760.00
Jul 31, 2022 3,530.00
Jul 31, 2022 3,530.00
Apr 30, 2022 173.00
Apr 30, 2022 173.00
Jan 31, 2022 -19,751.00
Jan 31, 2022 -19,751.00
Oct 31, 2021 -23,397.00
Oct 31, 2021 -23,397.00
Jul 31, 2021 -33,660.00
Jul 31, 2021 -33,660.00